Atrás
52
Rango del Día
$2.35
$3.16
Rango de 52 Semanas
$0.16
$3.33
Volumen
2,127
Promedio 50D / 200D
$2.71
/
$1.37
Cierre Anterior
$3.16
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -60.4 | 0.3 |
| P/B | 28.3 | 2.9 |
| ROE % | -44.5 | 3.7 |
| Net Margin % | -513.7 | 3.8 |
| Rev Growth 5Y % | 127.9 | 10.0 |
| D/E | 0.1 | 0.2 |
Precio Objetivo de Analistas
No hay cobertura de analistas disponible
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2029 |
$0.02
$0.01 – $0.03
|
110 M | 1 |
| FY2028 |
-$0.01
-$0.01 – $0.00
|
65 M | 1 |
| FY2027 |
-$0.04
-$0.07 – -$0.03
|
33 M | 1 |
Puntos Clave
Revenue grew 127.90% annually over 5 years — strong growth
Debt/Equity of 0.07 — conservative balance sheet
Negative free cash flow of -34.56M
PEG of 0.07 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 35.96%
Capital efficient — spends only 1.47% of revenue on capex
Crecimiento
Revenue Growth (5Y)
127.90%
Revenue (1Y)91.94%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-44.49%
ROIC-31.97%
Net Margin-513.72%
Op. Margin-499.20%
Seguridad
Debt / Equity
0.07
Current Ratio0.89
Interest Coverage0.00
Valoración
P/E Ratio
-60.36
P/B Ratio28.26
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 91.94% | Revenue Growth (3Y) | 185.41% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 127.90% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 5.85M | Net Income (TTM) | -30.07M |
| ROE | -44.49% | ROA | -31.72% |
| Gross Margin | 92.07% | Operating Margin | -499.20% |
| Net Margin | -513.72% | Free Cash Flow (TTM) | -34.56M |
| ROIC | -31.97% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.07 | Current Ratio | 0.89 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -60.36 | P/B Ratio | 28.26 |
| P/S Ratio | 310.07 | PEG Ratio | 0.07 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.81B | Enterprise Value | 1.81B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 5.85M | 3.05M | 718,581.0 | 1.05M | 216,978.0 |
| Net Income | -30.07M | -35.98M | -31.46M | -24.59M | -21.42M |
| EPS (Diluted) | -0.14 | -0.10 | -0.10 | -0.08 | -0.08 |
| Gross Profit | 5.39M | 2.81M | -24.28M | 280,617.0 | 125,125.0 |
| Operating Income | -29.22M | -46.61M | -30.65M | -22.20M | -13.69M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 94.81M | 120.02M | 92.92M | 74.31M | 92.64M |
| Total Liabilities | 30.58M | 49.09M | 21.46M | 14.80M | 9.28M |
| Shareholders' Equity | 64.24M | 70.93M | 71.46M | 59.51M | 83.36M |
| Total Debt | 4.31M | 5.12M | 5.14M | 6.24M | 1.69M |
| Cash & Equivalents | 6.88M | 30.61M | 69.58M | 51.11M | 80.88M |
| Current Assets | 17.06M | 39.05M | 78.54M | 58.85M | 85.85M |
| Current Liabilities | 19.25M | 21.89M | 17.07M | 9.56M | 8.17M |
Puntuaciones de Estrategias
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Full Throttle
#51 of 146
Actividad Reciente
Entró
Full Throttle
Mar 24, 2026